Metraipolis › archive › dc_838dfdbf38f4
The Gut Microbiome as a Biomarker and Therapeutic Target of Immune Checkpoint Inhibitors: A Review for Oncologists — Europe PMC PMID:41294832
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41294832
- DOI
- 10.3390/cells14221779
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T15:37:03.105Z
- SHA-256 of the archived text
bd7298cb389fa35ccf66f23ed3012a466481451ec816a73c6ee2e4428106f24a- Stable URL of this page
https://metraipolis.com/documento/dc_838dfdbf38f4
How to cite
The Gut Microbiome as a Biomarker and Therapeutic Target of Immune Checkpoint Inhibitors: A Review for Oncologists — Europe PMC PMID:41294832 — Europe PMC (en), https://europepmc.org/article/MED/41294832 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_838dfdbf38f4 (Metraipolis archive dc_838dfdbf38f4, sha256 bd7298cb389fa35ccf66f23ed3012a466481451ec816a73c6ee2e4428106f24a)
BibTeX
@misc{dc838dfdbf38f4,
title = {The Gut Microbiome as a Biomarker and Therapeutic Target of Immune Checkpoint Inhibitors: A Review for Oncologists — Europe PMC PMID:41294832},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41294832},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_838dfdbf38f4; sha256 bd7298cb389fa35ccf66f23ed3012a466481451ec816a73c6ee2e4428106f24a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41294832. Agents can read the archived copy with the MCP tool read_document.